Reicin Alise
An insider at 1 company in coverage, as reported on Form 4. SEC CIK 1757533. Latest Form 4 filed Oct 28, 2026.
Roles
As stated on the filings: the relationship to the company and any officer title.
| Company | Role | Transactions | First | Latest |
|---|---|---|---|---|
| Tectonic Therapeutic, Inc.TECX | Chief Executive Officer, Director, Officer | 2 | 2026-10-26 | 2026-10-26 |
Transactions: 2
Every transaction reported, newest first, including grants, exercises and derivative securities. Purchases and sales (codes P and S) are open-market trades. The reported price is as stated on the form.
What these mean: insiders, Form 4, transaction codes, Rule 10b5-1 plans.
| Date | Company | Transaction | Shares | Reported price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-10-26 | Tectonic Therapeutic, Inc.Chief Executive Officer, Director, Officer | Option exerciseEmployee Stock Option (Right to Buy) | 10,000 | not reported | not reported | Form 4 |
| 2026-10-26 | Tectonic Therapeutic, Inc.Chief Executive Officer, Director, Officer | Option exercise | 10,000 | $2.38 | $23.8k | Form 4 |
Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 30, 2026, 20:53 ET. Listed shows no prices and gives no investment advice.